EAST RUTHERFORD, N.J.–Cambrex signed a joint marketing and research & development (R&D) agreement with Las Vegas-based Skinvisible Inc. to develop cutting-edge acne formulations. Cambrex will utilize Skinvisible’s Invisicare® patented polymer delivery system to control the release of benzoyl peroxide or other actives for better efficacy with a reduction in active ingredient in the formula.